Rosalind Acquires Orchestra Bio Platform to Speed Coordination of Drug Development

Rosalind announced that it has acquired the Orchestra Bio platform, which helps coordinate biopharmaceutical development processes. With the acquisition, Rosalind aims to simplify operations and accelerate getting treatments to patients by building on AI models and tools; the company welcomed the Orchestra Bio team.